fashion -WSS

fashion

author：fashion 2025-09-06 01:57:44 - browse：27

Illustration of researchers working among oversized pill bottles, lab equipment, and medicine for story about the development of obesity medications – health and pharma coverage from STAT — Molly Ferguson for STAT

The exploding popularity of drugs like Wegovy and Mounjaro has propelled dozens of companies to develop their own obesity treatments, with most of them trying to emulate the same approach as the blockbuster products.

Nearly 70 obesity treatments are in development, and about two-thirds use a similar mechanism as Wegovy and Mounjaro, according to the STAT Obesity Drug Tracker, a new database compiled by STAT. There are also a minority of companies pursuing entirely different approaches, hoping that they will stand out among the field.

The tracker, which will be updated with significant developments each quarter, gives a sense of what new mechanisms could hit the market, how they would be delivered, and which companies are running the most trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

hotspot

WSS

Videos point to link between seizures and unexplained toddler deaths

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

California store owner shot dead in dispute over displaying Pride flag: Police

J&J to buy cancer drug developer Ambrx Biopharma

Trans patients at the end of life deserve respect and dignity

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

leisure time

fashion

leisure time

Duchenne breakthrough therapy leaves behind pioneering families

Health officials lay out plans to cope with respiratory virus season

Hepatitis C has a cure — but many Americans still lack access to it

FDA advisory panel to debate high blood pressure devices

BioMarin wins approval for gene therapy to treat hemophilia A

Feng Zhang CRISPR delivery startup lays off quarter of staff

Anesthesiologist group: stop taking Ozempic before surgery

Vivek Ramaswamy made waves in the debate, much as in biotech

In age of alternative facts, a scholarly course on calling out crap

Intellia plays down concerns on accidental germline transmission

focus

UCB departs biotech trade group BIO

Listen: Vivek Ramaswamy's star turn & leaky drug data

CDC says it’s too soon to assess risk posed by Covid subvariant

Former Pear Therapeutics executives start new VC firm

JPM: CVS says Medicare Advantage patients are impacting profits

California store owner shot dead in dispute over displaying Pride flag: Police

hotspot

hotspot

hotspot

hotspot